Abstract

Acute promyelocytic leukemia (APL) represents a paradigm for targeted differentiation therapy, with a minority of patients experiencing treatment failure and even early death. We here report a comprehensive single-cell analysis of 16 APL patients, uncovering cellular compositions and their impact on all-trans retinoic acid (ATRA) response in vivo and early death. We unveil a cellular differentiation hierarchy within APL blasts, rooted in leukemic stem-like cells. The oncogenic PML/RARα fusion protein exerts branch-specific regulation in the APL trajectory, including stem-like cells. APL cohort analysis establishes an association of leukemic stemness with elevated white blood cell counts and FLT3-ITD mutations. Furthermore, we construct an APL-specific stemness score, which proves effective in assessing early death risk. Finally, we show that ATRA induces differentiation of primitive blasts and patients with early death exhibit distinct stemness-associated transcriptional programs. Our work provides a thorough survey of APL cellular hierarchies, offering insights into cellular dynamics during targeted therapy.

The cellular hierarchies in acute promyelocytic leukemia (APL) remain to be explored. Here, the authors perform single-cell RNA sequencing of 16 APL patients to characterise its cellular composition and develop an APL-specific stemness score for assessing the risk of early death in APL.

Details

Title
Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia
Author
Jin, Wen 1   VIAFID ORCID Logo  ; Dai, Yuting 2   VIAFID ORCID Logo  ; Chen, Li 2   VIAFID ORCID Logo  ; Zhu, Honghu 3   VIAFID ORCID Logo  ; Dong, Fangyi 2 ; Zhu, Hongming 2 ; Meng, Guoyu 2   VIAFID ORCID Logo  ; Li, Junmin 2 ; Chen, Saijuan 2   VIAFID ORCID Logo  ; Chen, Zhu 1 ; Fang, Hai 2   VIAFID ORCID Logo  ; Wang, Kankan 1   VIAFID ORCID Logo 

 State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293); Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Sino-French Research Center for Life Sciences and Genomics, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Hematology, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Beijing Chao-Yang Hospital, Capital Medical University, Department of Hematology, Beijing, China (GRID:grid.411607.5) 
Pages
1423
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2927741617
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.